Potential	O
Sunitinib	B:C1176020
-	O
Induced	O
Coronary	O
Artery	I:C0205042
and	O
Aortic	O
Dissections	I:C0340643
.	O

Potential	O
Sunitinib	O
-	O
Induced	O
Coronary	B:C0205042
Artery	I:C0205042
and	O
Aortic	O
Dissections	I:C0340643
.	O

Potential	O
Sunitinib	O
-	O
Induced	O
Coronary	O
Artery	I:C0205042
and	O
Aortic	B:C0340643
Dissections	I:C0340643
.	O

Small	B:C0879484
-	I:C0879484
molecule	I:C0879484
multitargeted	I:C0879484
tyrosine	I:C0879484
kinase	I:C0879484
inhibitor	I:C0879484
(	I:C0879484
TKI	I:C0879484
)	I:C0879484
therapy	I:C0879484
is	O
used	O
in	O
different	O
types	O
of	O
cancer	O
.	O

Small	O
-	I:C0879484
molecule	I:C0879484
multitargeted	I:C0879484
tyrosine	I:C0879484
kinase	I:C0879484
inhibitor	I:C0879484
(	I:C0879484
TKI	I:C0879484
)	I:C0879484
therapy	I:C0879484
is	O
used	O
in	O
different	O
types	O
of	O
cancer	B:C0006826
.	O

These	O
drugs	B:C0013227
have	O
been	O
associated	O
with	O
cardiovascular	O
toxicity	I:C0876994
,	O
including	O
aortic	O
dissection	I:C0340643
.	O

These	O
drugs	O
have	O
been	O
associated	O
with	O
cardiovascular	B:C0876994
toxicity	I:C0876994
,	O
including	O
aortic	O
dissection	I:C0340643
.	O

These	O
drugs	O
have	O
been	O
associated	O
with	O
cardiovascular	O
toxicity	I:C0876994
,	O
including	O
aortic	B:C0340643
dissection	I:C0340643
.	O

To	O
our	O
knowledge	B:C0376554
,	O
this	O
is	O
the	O
first	O
time	O
that	O
a	O
coronary	O
dissection	I:C0340643
potentially	O
associated	O
with	O
a	O
TKI	O
treatment	I:C0879484
has	O
been	O
described	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
time	O
that	O
a	O
coronary	B:C0340643
dissection	I:C0340643
potentially	O
associated	O
with	O
a	O
TKI	O
treatment	I:C0879484
has	O
been	O
described	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
time	O
that	O
a	O
coronary	O
dissection	I:C0340643
potentially	O
associated	O
with	O
a	O
TKI	B:C0879484
treatment	I:C0879484
has	O
been	O
described	O
.	O

